Voloridge Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52,835
| Closed | -$2.08M | – | 1202 |
|
|
2024
Q4 | $2.08M | Sell |
52,835
-113,428
| -68% | -$4.46M | 0.01% | 939 |
|
|
2024
Q3 | $7.81M | Buy |
+166,263
| New | +$7.81M | 0.03% | 655 |
|
|
2024
Q2 | – | Sell |
-44,312
| Closed | -$3.02M | – | 1225 |
|
|
2024
Q1 | $3.02M | Sell |
44,312
-682,575
| -94% | -$46.5M | 0.01% | 763 |
|
|
2023
Q4 | $45.5M | Buy |
+726,887
| New | +$45.5M | 0.18% | 156 |
|
|
2023
Q3 | – | Sell |
-25,642
| Closed | -$1.44M | – | 1414 |
|
|
2023
Q2 | $1.44M | Sell |
25,642
-40,482
| -61% | -$2.27M | 0.01% | 1046 |
|
|
2023
Q1 | $2.99M | Buy |
+66,124
| New | +$2.99M | 0.01% | 845 |
|
|
2022
Q4 | – | Sell |
-15,380
| Closed | -$1.01M | – | 1469 |
|
|
2022
Q3 | $1.01M | Sell |
15,380
-132,710
| -90% | -$8.67M | 0.01% | 1163 |
|
|
2022
Q2 | $9M | Sell |
148,090
-231,144
| -61% | -$14M | 0.05% | 479 |
|
|
2022
Q1 | $23.8M | Buy |
379,234
+163,605
| +76% | +$10.3M | 0.14% | 219 |
|
|
2021
Q4 | $16.3M | Buy |
215,629
+212,906
| +7,819% | +$16.1M | 0.09% | 318 |
|
|
2021
Q3 | $305K | Sell |
2,723
-1,860
| -41% | -$208K | ﹤0.01% | 1530 |
|
|
2021
Q2 | $742K | Sell |
4,583
-36,676
| -89% | -$5.94M | 0.01% | 1344 |
|
|
2021
Q1 | $5.03M | Buy |
41,259
+12,068
| +41% | +$1.47M | 0.04% | 531 |
|
|
2020
Q4 | $4.47M | Buy |
+29,191
| New | +$4.47M | 0.04% | 487 |
|
|
2020
Q1 | – | Sell |
-59,617
| Closed | -$3.63M | – | 1139 |
|
|
2019
Q4 | $3.63M | Buy |
+59,617
| New | +$3.63M | 0.07% | 352 |
|
|
2019
Q1 | – | Sell |
-62,580
| Closed | -$1.79M | – | 950 |
|
|
2018
Q4 | $1.79M | Buy |
+62,580
| New | +$1.79M | 0.08% | 209 |
|